Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions

Fact Sheets

Published 3/13/23
federal policy brief

Autoimmune diseases are estimated to affect anywhere between 23.5 and 50 million Americans, and recent evidence has shown that the prevalence of autoimmune biomarkers is increasing in the United States, with a disproportionate impact on women. The needs within autoimmune disease research are varied and numerous –ranging from a need to reach consensus on which illness are autoimmune diseases, what the underlying mechanisms of autoimmune diseases are, and how to prevent or reduce autoimmunity risk factors.

Taken together, these issues demonstrate a pressing need to make autoimmune diseases and conditions a greater national priority. The Society for Women’s Health Research developed the policy brief, “Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions,” to discuss the state of autoimmune disease research funding and highlight how robust and sustained support for this research could improve our understanding of disease pathology and inform the development of improved diagnostic tools and new treatments and interventions.

Download the Policy Brief

Read More SWHR Autoimmune Policy Briefs

Issues Affecting Health Care Coverage and Access for Women with Autoimmune Diseases and Conditions

This policy brief highlights how certain coverage policies, such as prior authorization and step therapy, can affect women and their health care providers and shares policy recommendations that could improve outcomes.

Learn More